PEA

Suspected endocannabinoid.

OEA

Suspected endocannabinoid.

2AGE/Noladin

Suspected cannabinoid that binds to several cannabinoid receptors.

2AG

2AG is a major endocannabinoid produced from lipids in cellular membranes, mostly but not exclusively in response to cellular activity.

Anandamide

Anandamide was the first identified endocannabinoid, named after the Sanskrit 'ananda' for inner bliss. Anandamide is produced from lipids in cellular membranes throughout the body.

Psychosis and Schizophrenia

Schizophrenia is a chronic mental disorder that affects around 1% of the worldwide population. It causes psychotic behaviors, social and emotional disruptions and different cognitive impairments.

The causes of the disease are still not clear but studies show that both genetic and environmental factors have an effect on it.

Psoriasis

Psoriasis is an auto-immune disease characterized by itchy skin lesions. Psoriasis arises when the immune system mistakenly identifies skin cells as foreign matter and causes over-production of new skin cells.

Obesity

Energy homeostasis (balance)  is one of the primary functions of the endocannabinoid system.

Migraine

Migraine is a chronic neurological disorder that is mostly characterized by severe headaches and aura.

Hypoxic-ischemic encephalopathy

Hypoxic-ischemic encephalopathy is a form of brain injury caused by oxygen deprivation during the birth process. It can cause sensorimotor and cognitive impairments including physical and intellectual disability. The endocannabinoid system can regulate the underlying processes of hypoxic-ischemic encephalopathy when its occurring, therefore cannabinoids could help to ameliorate the symptoms related to it.